This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Xiaohua Zhang
Introduction
Xiaohua Zhang is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit α-amylase. Her work has implications for various health-related applications, especially in the management of diabetes and obesity.
Latest Patents
Xiaohua Zhang holds a patent for "Amylase inhibitor compounds, methods of their use and compositions thereof." This patent includes compounds of Formula I, which are designed to inhibit α-amylase, an enzyme that plays a crucial role in carbohydrate digestion. The innovative methods and compositions outlined in her patent provide valuable tools for addressing metabolic disorders.
Career Highlights
Zhang is affiliated with the University of British Columbia, where she conducts her research and collaborates with other experts in her field. Her academic background and research focus have positioned her as a leader in the study of enzyme inhibitors.
Collaborations
Throughout her career, Xiaohua Zhang has worked alongside notable colleagues such as Stephen G. Withers and Gary D. Brayer. These collaborations have enhanced her research and contributed to the advancement of knowledge in enzyme inhibition.
Conclusion
Xiaohua Zhang's innovative work in developing amylase inhibitor compounds showcases her dedication to advancing scientific understanding and improving health outcomes. Her contributions continue to influence the field of biochemistry and offer promising solutions for managing metabolic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
